Literature DB >> 6546998

Distribution and characterization of synenkephalin immunoreactivity in the bovine brain and pituitary.

D Liston, J Rossier.   

Abstract

The distribution of synenkephalin, the N-terminal fragment of proenkephalin, was studied in various parts of the bovine brain (globus pallidus, caudate nucleus, hypothalamus) and in the posterior pituitary by the use of a radioimmunoassay. The distribution of synenkephalin-immunoreactivity (IR) was compared to the distribution of Met-enkephalin-IR. Gel exclusion chromatography was used to examine the molecular forms of the immunoreactivities present in the tissues. The distribution of synenkephalin-IR was similar to the distribution of Met-enkephalin-IR, with a molar ratio of Met-enkephalin/synenkephalin ranging between 2.7 and 5.9. In all regions tested except the hypothalamus the synenkephalin-IR was present as a single species. However, in the hypothalamus a small amount of IR material (3% of the total synenkephalin-IR) was detected in fractions where larger Met-enkephalin-containing peptides eluted. Based on the concordance between the molar ratio of Met-enkephalin to synenkephalin found in the tissues and the molar ratio present in the sequence of adrenal proenkephalin, it is concluded that the brain and adrenal glands utilize a similar precursor for enkephalin biosynthesis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6546998     DOI: 10.1016/0167-0115(84)90031-4

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  2 in total

1.  Regulated expression of proenkephalin A during ontogenic development of mesenchymal derivative tissues.

Authors:  R D Polakiewicz; H Rosen
Journal:  Mol Cell Biol       Date:  1990-02       Impact factor: 4.272

2.  Expression of the human proenkephalin gene in mouse pituitary cells: accurate and efficient mRNA production and proteolytic processing.

Authors:  M Comb; D Liston; M Martin; H Rosen; E Herbert
Journal:  EMBO J       Date:  1985-12-01       Impact factor: 11.598

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.